LIMD1‐AS1 suppressed NSCLC progression through stabilizing LIMD1 mRNA via hnRNP U, providing new thoughts for the improvement of molecular‐targeted therapy for NSCLC. The gene discussed is HNRNPU; the disease is non-small cell lung carcinoma.